Priority Date: 25.10.11 (JP 20110233965)
HETEROCYCLE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONIST ACTIVITY
- Application ID: EP12844230
- Status: █ PATENT GRANTED
Applicant
Technology Company
Attorney
operating since 1894
Headquarter in London
and
5 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
Specialization
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 233 others are specialized in this combination either. For a similar patent, they might be a good choice.
Timeline
- 25.10.2011 - Priority Date (JP 20110233965)
- 02.05.2013 - Publication A1 (WO2013061977)
- 09.07.2014 - Publication A1 (EP2752410)
- 31.08.2016 - Publication B1 (EP2752410)